Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | PADI1 | Q9ULC6 | 2/20 | 0.35 |
| ▸ | PADI4 | Q9UM07 | 2/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
| ▸ | HRH2 | P25021 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | MLNR | O43193 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19249465 | 0.84 | MEN1 (0.37) | MEN1KMT2ACHRM5CHRM3PADI1 | |
| SCHEMBL19954033 | 0.84 | MEN1 (0.37) | MEN1KMT2ACHRM5CHRM3PADI1 | |
| SCHEMBL23372759 | 0.83 | SIGMAR1 (0.40) | MEN1KMT2ACHRM5CHRM3PADI1 | |
| SCHEMBL21148006 | 0.80 | TDP1 (0.48) | KMT2ASMN1; SMN2 | |
| SCHEMBL23199266 | 0.79 | ALDH1A1 (0.43) | MEN1KMT2ACHRM5CHRM3PADI1 | |
| SCHEMBL2222768 | 0.78 | DGKA (0.51) | MEN1KMT2ASIGMAR1HRH2HRH1 | |
| SCHEMBL2219074 | 0.78 | DGKA (0.51) | MEN1KMT2ASIGMAR1HRH2HRH1 | |
| Hydrochloric Acid SCHEMBL27945157 | 0.77 | ALDH1A1 (0.42) | MEN1KMT2ACHRM5CHRM3PADI1 | |
| Hydrochloric Acid SCHEMBL2221631 | 0.76 | GNAI3 (0.52) | MEN1KMT2AHRH2HRH1 | |
| SCHEMBL29926123 | 0.75 | MEN1 (0.41) | MEN1KMT2ACHRM5CHRM3MLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9914719-B2 | Hydroxybenzamide derivatives and their use as inhibitors of HSP90 | ASTEX THERAPEUTICS LTD. (GB) | 2018-03-13 | — | — | US | disclosed |